Published in Curr Med Res Opin on July 01, 2010
Diagnosing and managing postherpetic neuralgia. Drugs Aging (2012) 1.26
Complications of varicella zoster virus reactivation. Curr Treat Options Neurol (2013) 1.04
Treatment of localized post-traumatic neuropathic pain in scars with 5% lidocaine medicated plaster. Local Reg Anesth (2010) 0.90
The humanistic, economic and societal burden of herpes zoster in Europe: a critical review. BMC Public Health (2015) 0.87
Building a diagnostic algorithm on localized neuropathic pain (LNP) and targeted topical treatment: focus on 5% lidocaine-medicated plaster. Ther Clin Risk Manag (2014) 0.86
Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain. Ther Adv Drug Saf (2014) 0.82
Use of 5% lidocaine medicated plaster to treat localized neuropathic pain secondary to traumatic injury of peripheral nerves. Local Reg Anesth (2012) 0.81
Options for treating postherpetic neuralgia in the medically complicated patient. Ther Clin Risk Manag (2013) 0.81
Reduction of painful area as new possible therapeutic target in post-herpetic neuropathic pain treated with 5% lidocaine medicated plaster: a case series. J Pain Res (2014) 0.81
The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence. J Pain Res (2016) 0.79
5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability. Pain Ther (2015) 0.77
Skin Matters: A Review of Topical Treatments for Chronic Pain. Part Two: Treatments and Applications. Pain Ther (2015) 0.76
5% lidocaine medicated plaster double effect in a case of orofacial localized neuropathic pain. J Pain Res (2014) 0.76
Can treatment success with 5% lidocaine medicated plaster be predicted in cancer pain with neuropathic components or trigeminal neuropathic pain? J Pain Res (2013) 0.75
The 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its Use. Pain Ther (2016) 0.75
Topical Treatments for Localized Neuropathic Pain. Curr Pain Headache Rep (2017) 0.75
Add-on treatment with pregabalin for patients with uncontrolled neuropathic pain who have been referred to pain clinics. Clin Drug Investig (2014) 0.75
painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin (2006) 4.78
NeuPSIG guidelines on neuropathic pain assessment. Pain (2010) 4.04
Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc (2010) 3.92
Pseudoradicular and radicular low-back pain--a disease continuum rather than different entities? Answers from quantitative sensory testing. Pain (2007) 3.91
A new definition of neuropathic pain. Pain (2011) 3.57
Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol (2010) 3.31
Interventional management of neuropathic pain: NeuPSIG recommendations. Pain (2013) 2.75
The Pharmacological Therapy of Chronic Neuropathic Pain. Dtsch Arztebl Int (2016) 2.45
Is CRPS I a neuropathic pain syndrome? Pain (2006) 2.40
Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron (2012) 2.11
Using screening tools to identify neuropathic pain. Pain (2006) 2.09
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain (2012) 1.88
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain (2010) 1.84
Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol (2011) 1.83
Pain in oxaliplatin-induced neuropathy--sensitisation in the peripheral and central nociceptive system. Eur J Cancer (2007) 1.83
Complex regional pain syndrome: mystery explained? Lancet Neurol (2003) 1.75
Sensory signs in complex regional pain syndrome and peripheral nerve injury. Pain (2011) 1.70
Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain (2013) 1.60
Topical menthol--a human model for cold pain by activation and sensitization of C nociceptors. Brain (2004) 1.58
Influence of deep brain stimulation and levodopa on sensory signs in Parkinson's disease. Mov Disord (2010) 1.55
Who is healthy? Aspects to consider when including healthy volunteers in QST-based studies-a consensus statement by the EUROPAIN and NEUROPAIN consortia. Pain (2015) 1.47
Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting. Pain (2015) 1.44
Different underlying pain mechanisms despite identical pain characteristics: a case report of a patient with spinal cord injury. Pain (2012) 1.43
Complex regional pain syndrome-a multifaceted disorder requiring multidimensional care: case study. J Pain (2007) 1.42
The evaluation of neuropathic components in low back pain. Curr Pain Headache Rep (2009) 1.40
Do we need a third mechanistic descriptor for chronic pain states? Pain (2016) 1.39
Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approach. Lancet Neurol (2012) 1.37
Translation of symptoms and signs into mechanisms in neuropathic pain. Pain (2003) 1.36
The motor system shows adaptive changes in complex regional pain syndrome. Brain (2007) 1.36
Reference data for quantitative sensory testing (QST): refined stratification for age and a novel method for statistical comparison of group data. Pain (2010) 1.36
Screening of neuropathic pain components in patients with chronic back pain associated with nerve root compression: a prospective observational pilot study (MIPORT). Curr Med Res Opin (2006) 1.34
Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care--short version. Ger Med Sci (2010) 1.30
Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient. Drugs Aging (2008) 1.28
Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain (2003) 1.28
5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study. Curr Med Res Opin (2009) 1.23
Sensory symptom profiles and co-morbidities in painful radiculopathy. PLoS One (2011) 1.23
A cross-sectional survey of 3035 patients with fibromyalgia: subgroups of patients with typical comorbidities and sensory symptom profiles. Rheumatology (Oxford) (2010) 1.17
Postherpetic neuralgia: epidemiology, pathophysiology and management. Expert Rev Neurother (2007) 1.16
Harlequin syndrome--one face of many etiologies. Nat Clin Pract Neurol (2005) 1.15
Receptor kinase signaling pathways in plant-microbe interactions. Annu Rev Phytopathol (2012) 1.15
Assessment of neuropathic pain in primary care. Am J Med (2009) 1.14
FRET-based genetically encoded sensors allow high-resolution live cell imaging of Ca²⁺ dynamics. Plant J (2011) 1.13
Modelling the prevalence and cost of back pain with neuropathic components in the general population. Eur J Pain (2009) 1.12
Complex regional pain syndrome is a disease of the central nervous system. Clin Auton Res (2002) 1.12
Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel. BMC Neurol (2011) 1.11
Skin temperature side differences--a diagnostic tool for CRPS? Pain (2002) 1.11
Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial. Clin Drug Investig (2009) 1.09
TILLING in Lotus japonicus identified large allelic series for symbiosis genes and revealed a bias in functionally defective ethyl methanesulfonate alleles toward glycine replacements. Plant Physiol (2009) 1.09
Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin. J Neurol (2005) 1.07
Fibromyalgia and neuropathic pain--differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia. BMC Neurol (2011) 1.04
Transient receptor potential channel polymorphisms are associated with the somatosensory function in neuropathic pain patients. PLoS One (2011) 1.02
The effect of menthol on cold allodynia in patients with neuropathic pain. Pain Med (2008) 1.01
Assessing symptom profiles in neuropathic pain clinical trials: can it improve outcome? Eur J Pain (2011) 0.98
Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study. Curr Med Res Opin (2012) 0.97
Idiopathic restless legs syndrome: abnormalities in central somatosensory processing. J Neurol (2004) 0.97
Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study. Curr Med Res Opin (2009) 0.97
Toward a definition of pharmacoresistant neuropathic pain. Eur J Pain (2009) 0.96
Complex regional pain syndrome type I: neuropathic or not? Curr Pain Headache Rep (2010) 0.96
Effects of subthalamic nucleus stimulation and levodopa on the autonomic nervous system in Parkinson's disease. J Neurol Neurosurg Psychiatry (2007) 0.95
The relation between small nerve fibre function, age, disease severity and pain in Fabry disease. Eur J Pain (2011) 0.92
Painful or painless lower limb dysesthesias are highly predictive of peripheral neuropathy: comparison of different diagnostic modalities. Eur J Pain (2008) 0.91
Paper versus electronic rating scales for pain assessment: a prospective, randomised, cross-over validation study with 200 chronic pain patients. Curr Med Res Opin (2008) 0.91
A role for peripheral afferents in the pathophysiology and treatment of at-level neuropathic pain in spinal cord injury? A case report. Pain (2007) 0.91
Department-related tasks and organ-targeted therapy in Fabry disease: an interdisciplinary challenge. Am J Med (2010) 0.90
Treatment considerations for elderly and frail patients with neuropathic pain. Mayo Clin Proc (2010) 0.90
Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. Curr Med Res Opin (2009) 0.90
Docetaxel-induced nail changes--a neurogenic mechanism: a case report. J Neurooncol (2002) 0.89
What is localized neuropathic pain? A first proposal to characterize and define a widely used term. Pain Manag (2012) 0.89
Neuropathic pain: an updated grading system for research and clinical practice. Pain (2016) 0.87
Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia. Curr Med Res Opin (2012) 0.87
Phenotyping neuropathic pain patients: implications for individual therapy and clinical trials. Curr Opin Support Palliat Care (2014) 0.87
From dead leaf, to new life: TAL effectors as tools for synthetic biology. Plant J (2014) 0.86
Axial low back pain: one painful area--many perceptions and mechanisms. PLoS One (2013) 0.86
Understanding chronic inflammatory and neuropathic pain. Ann N Y Acad Sci (2012) 0.85
How to detect a sensory abnormality. Eur J Pain (2008) 0.84
Experimental approach to CRPS. Pain (2004) 0.84
Detection of a characteristic painful neuropathy in Fabry disease: a pilot study. Pain Med (2008) 0.84
Topical high-concentration (40%) menthol-somatosensory profile of a human surrogate pain model. J Pain (2011) 0.84
Evaluation of symptom heterogeneity in neuropathic pain using assessments of sensory functions. Neurotherapeutics (2009) 0.83
Spinal and supraspinal processing of thermal stimuli: an fMRI study. J Magn Reson Imaging (2014) 0.83
A case of neuropathic brachioradial pruritus caused by cervical disc herniation. Nat Clin Pract Neurol (2008) 0.82
Disease mechanisms in neuropathic itch. Nat Clin Pract Neurol (2008) 0.82
Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial. Clin Drug Investig (2009) 0.82
Effect of local and intravenous lidocaine on ongoing activity in injured afferent nerve fibers. Pain (2011) 0.82
Cutaneous afferent C-fibers regenerating along the distal nerve stump after crush lesion show two types of cold sensitivity. Eur J Pain (2008) 0.82
Behavioral and sensory changes after direct ischemia-reperfusion injury in rats. Eur J Pain (2006) 0.82